Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / General / February 2005

Tip: Looking for answers? Try searching our database.

Apheresis / active distal ulcerative colitis

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ironjustice@aol.com - 01 Feb 2005 12:53 GMT
Aliment Pharmacol Ther. 2004 Oct 1;20(7):783-92. Related Articles,
Links

Granulocyte and monocyte adsorptive apheresis in the treatment of
active distal ulcerative colitis: a prospective, pilot study.

Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D,
Mukumoto M, Nishimura N, Yasue K, Matsumoto K.

Inflammatory Bowel Disease Centre, Yokkaichi Social Insurance Hospital,
Yokkaichi, Mie, Japan. nao-taka@sannet.ne.jp

AIM: To assess safety and clinical efficacy of granulocyte and monocyte
adsorptive apheresis for distal ulcerative colitis. METHODS:
Granulocyte and monocyte adsorptive apheresis therapy (five aphereses
for 5 consecutive weeks) was performed for 30 consecutive patients with
active distal ulcerative colitis. Patient compliance, adverse effects
and clinical symptoms were regularly assessed. RESULTS: Adverse effects
were noted during nine (6%) apheresis sessions in eight patients;
slight headache five, transient abdominal pain with tenesmus two, fever
(38 degrees C) one and mild liver dysfunction one. None of these
adverse effects was serious and all patients could complete five
aphereses. Clinical symptoms (stool frequency and consistency, rectal
bleeding, tenesmus and mucus in stools) significantly improved after
the third apheresis. Clinical remission (normal stool frequency and no
rectal bleeding) was achieved in 21 patients (70%) after five
aphereses. The median Disease Activity Index score significantly
decreased; from 6 [interquartile range (IQR): 4-7] to 2 (IQR: 1-3) (P <
0.0001). CONCLUSION: In the treatment of active distal ulcerative
colitis, granulocyte and monocyte adsorptive apheresis is safe and
well-tolerated. Granulocyte and monocyte adsorptive apheresis had a
beneficial effect on clinical remission and symptoms. However,
randomized-controlled trials would be necessary to assess a definite
efficacy of granulocyte and monocyte adsorptive apheresis.

PMID: 15379839 [PubMed - indexed for MEDLINE]

--------------------------------------------------------------------------------
Who loves ya.
Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
Lisa S. Quinn - 01 Feb 2005 13:19 GMT
I was a participant in the clinical trials treating Crohn's Disease with
this process and can speak to it's success!  Not only did I come very close
to total remission for a short period of time, the sole benefit of NOT
taking any drugs was nirvana!!  I really hope it becomes an FDA approved
treatment here in the states SOON!!!!

Signature

~Lisa S. Quinn
"Criticize the words they're selling - Think for yourself and feel the walls
become like sand beneath your feet...."

> Aliment Pharmacol Ther. 2004 Oct 1;20(7):783-92. Related Articles,
> Links
[quoted text clipped - 41 lines]
> DEAD PEOPLE WALKING
> http://pages.ivillage.com/ironjustice/deadpeoplewalking
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.